1 Day
Source:
المشهد العربي
Pharma giants commit $500B investment in US
Global pharmaceutical companies, including Eli Lilly, Pfizer, and AstraZeneca, have announced investment commitments worth up to $500 billion over the past two years and the current year in the United States. The goal is to increase manufacturing capacity and strengthen research and development. This move comes amid political pressure to localize pharmaceutical manufacturing, especially after Trump's threats to impose tariffs of up to 100% on imported medications and the U.S. government’s call to expand operations domestically.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)